| |
Receive E-mail Alerts | Alerts are e-mailed to you whenever certain new company information is posted to this site.
Sign-up Now! |
|
Arena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing innovative oral drugs for patients with serious diseases and disorders, such as obesity and insomnia. We have a diverse portfolio of drug candidates, both proprietary and partnered. Our lead proprietary drug candidate, lorcaserin hydrochloride, is intended for the treatment of obesity and is being evaluated in a Phase 3 clinical program. |
| The stock information, SEC filings and press releases included on this website are not provided by Arena Pharmaceuticals, Inc. but by a third-party. Such information is not intended for trading purposes. Arena Pharmaceuticals, Inc. does not guarantee the accuracy or completeness of this information and is not liable in any way whatsoever for any delays, inaccuracies, errors in, or omissions of any such information, or for any actions taken in reliance on this information, or for any damages arising there from.
|
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. |
|
